Supreme Court to review $21M verdict for NH woman injured by generic drug

The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain.
CLICK TO VIEW THE SOURCE MATERIAL